micro-community-banner
 
  • Saved

2w
Advances in lung health and sleep medicine: Key highlights from CHEST 2025

At CHEST 2025 in Chicago, pulmonology experts shared new insights in asthma, COPD, interstitial lung disease, pulmonary hypertension, and sleep medicine. Dr. Sandhya Khurana highlighted emerging asthma data—such as imaging-based reductions in mucus plugging and outcomes in severe asthma with nasal polyps—while also discussing the future of nanobody therapeutics. Dr. Cosmo Fowler reviewed GLP-1 RA–linked survival benefits in OSA.

Share your thoughts

  • Saved

2w
infographic
  • Saved

3w
Background Image DesktopBackground Image Mobile

Next-Generation Sequencing (NGS) enables molecular autopsy in unexplained Sudden Cardiac Death (SCD) among the young. It identifies inherited cardiac disorders, aiding diagnosis and guiding family risk. VUS interpretation remains a diagnostic challenge.

Explore Molecular Autopsy with NGS today

  • Saved

3w

Did you know? In a recent study of acute cardiological emergencies, ChatGPT-4o matched cardiologists with 100% accuracy and far outpaced emergency physicians. With an average response time of just 11.27 minutes, it proved faster and more precise—highlighting AI’s potential as a reliable assistant in urgent care settings.

How might AI's unparalleled speed and high accuracy in critical medical scenarios enhance clinical decision-making in emergency departments?

NCCN Guidelines

How might AI's unparalleled speed and high accuracy in critical medical scenarios enhance clinical decision-making in emergency departments?

  • Saved

3w
Efficacy and safety of apixaban and warfarin in prevention of ischemic stroke: a systematic review and meta-analysis - PubMed

Efficacy and safety of apixaban and warfarin in prevention of ischemic stroke: a systematic review and meta-analysis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/40395880/

Apixaban has more advantages and a higher safety profile than warfarin, making it worthy of widespread use.

This meta-analysis of 11 studies (n=240,652) found apixaban and warfarin have similar efficacy for ischemic stroke prevention, but apixaban significantly reduces major bleeding, intracranial hemorrhage, and gastrointestinal bleeding—supporting its safer profile for anticoagulation in atrial fibrillation.